- Filed
- May 7, 2019 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2019 · Apr 26, 2019 | 109.24M sh |
| Shares Diluted | Q2 2019 · Mar 31, 2019 | 110M sh |
| Shares Diluted | Q2 2019 · Mar 31, 2019 | 109.9M sh |
| Shares Diluted | Q2 2019 · Mar 31, 2018 | 109.7M sh |
| Shares Diluted | Q2 2019 · Mar 31, 2018 | 109.8M sh |
| Dividends Paid | Q2 2019 · Mar 31, 2019 | $17.6M |
| Dividends Paid | Q2 2019 · Mar 31, 2018 | $10.9M |
| Capex | Q2 2019 · Mar 31, 2019 | $45M |
| Capex | Q2 2019 · Mar 31, 2018 | $65.1M |
| Operating Cash Flow | Q2 2019 · Mar 31, 2019 | $73.3M |
| Operating Cash Flow | Q2 2019 · Mar 31, 2018 | $56.5M |
| Long Term Debt | Q2 2019 · Mar 31, 2019 | $972.2M |
| Long Term Debt | Q2 2019 · Sep 30, 2018 | $974.2M |
| Short Term Debt | Q2 2019 · Mar 31, 2019 | $300K |
| Short Term Debt | Q2 2019 · Sep 30, 2018 | $0 |
| Short Term Investments | Q2 2019 · Mar 31, 2019 | $11.4M |
| Short Term Investments | Q2 2019 · Sep 30, 2018 | $0 |
| Cash And Equivalents | Q2 2019 · Mar 31, 2019 | $390.8M |
| Cash And Equivalents | Q2 2019 · Sep 30, 2018 | $399.8M |
| Cash And Equivalents | Q2 2019 · Mar 31, 2018 | $254.4M |
| Cash And Equivalents | Q2 2019 · Sep 30, 2017 | $271.4M |
| Stockholders Equity | Q2 2019 · Mar 31, 2019 | $269.6M |
| Stockholders Equity | Q2 2019 · Sep 30, 2018 | $178.5M |
| Current Liabilities | Q2 2019 · Mar 31, 2019 | $164.3M |
| Current Liabilities | Q2 2019 · Sep 30, 2018 | $187.7M |
| Total Liabilities | Q2 2019 · Mar 31, 2019 | $1.26B |
| Total Liabilities | Q2 2019 · Sep 30, 2018 | $1.29B |
| Current Assets | Q2 2019 · Mar 31, 2019 | $865.8M |
| Current Assets | Q2 2019 · Sep 30, 2018 | $813.1M |
| Total Assets | Q2 2019 · Mar 31, 2019 | $1.57B |
| Total Assets | Q2 2019 · Sep 30, 2018 | $1.51B |
| Eps Diluted | Q2 2019 · Mar 31, 2019 | $0.46 |
| Eps Diluted | Q2 2019 · Mar 31, 2019 | $1.01 |
| Eps Diluted | Q2 2019 · Mar 31, 2018 | $0.56 |
| Eps Diluted | Q2 2019 · Mar 31, 2018 | $0.73 |
| Eps Basic | Q2 2019 · Mar 31, 2019 | $0.46 |
| Eps Basic | Q2 2019 · Mar 31, 2019 | $1.02 |
| Eps Basic | Q2 2019 · Mar 31, 2018 | $0.57 |
| Eps Basic | Q2 2019 · Mar 31, 2018 | $0.74 |
| Sga Expense | Q2 2019 · Mar 31, 2019 | $32.6M |
| Sga Expense | Q2 2019 · Mar 31, 2019 | $68.1M |
| Sga Expense restated | Q2 2019 · Mar 31, 2018 | $36.5M |
| Sga Expense restated | Q2 2019 · Mar 31, 2018 | $71.8M |
| Rd Expense | Q2 2019 · Mar 31, 2019 | $11.1M |
| Rd Expense | Q2 2019 · Mar 31, 2019 | $24M |
| Rd Expense | Q2 2019 · Mar 31, 2018 | $11.1M |
| Rd Expense | Q2 2019 · Mar 31, 2018 | $23.8M |
| Net Income | Q2 2019 · Mar 31, 2019 | $50.4M |
| Net Income | Q2 2019 · Mar 31, 2019 | $111.5M |
| Net Income | Q2 2019 · Mar 31, 2018 | $61.6M |
| Net Income restated | Q2 2019 · Mar 31, 2018 | $80.3M |
| Operating Income | Q2 2019 · Mar 31, 2019 | $82.6M |
| Operating Income | Q2 2019 · Mar 31, 2019 | $178.4M |
| Operating Income restated | Q2 2019 · Mar 31, 2018 | $89.6M |
| Operating Income restated | Q2 2019 · Mar 31, 2018 | $178.9M |
| Cost Of Revenue | Q2 2019 · Mar 31, 2019 | $189.8M |
| Cost Of Revenue | Q2 2019 · Mar 31, 2019 | $385.9M |
| Cost Of Revenue restated | Q2 2019 · Mar 31, 2018 | $195.8M |
| Cost Of Revenue restated | Q2 2019 · Mar 31, 2018 | $387M |
| Revenue | Q2 2019 · Mar 31, 2019 | $326.2M |
| Revenue | Q2 2019 · Mar 31, 2019 | $665.7M |
| Revenue | Q2 2019 · Mar 31, 2018 | $340.7M |
| Revenue | Q2 2019 · Mar 31, 2018 | $671.5M |